Artificial intelligence (AI) is transforming healthcare through automation, analytics, and smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.
AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
AI consulting and support services are driving healthcare’s administrative automation and clinical decision support. AI hardware, including robotics and imaging systems, underpins advances in the medical device sector, while AI platforms and specialized applications are reshaping pharmaceutical research and development (R&D). Collectively, these technologies are moving AI from pilots to scaled commercial adoption.
Report Scope
- AI adoption is accelerating across healthcare sectors.
- AI boosts efficiency in drug discovery and development.
- Regulatory progress accelerates adoption of AI imaging tools.
Reasons to Buy
- Understand how AI is being used in the healthcare sector.
- Learn about the major players in AI in healthcare, and where the future of AI in healthcare is going.
- Access valuable strategic information to enhance future decision-making and inform new product development.
Table of Contents
- Executive Summary
- Players
- Value Chain
- The Impact of AI on Film and TV
- Case Studies
- Companies
- Sector Scorecard
- Glossary
- Further Reading
- Thematic Research Methodology
- Report Authors
- About the Analyst
- Contact the Publisher
Table 1 page 18-20: Leading AI adopters in film and TV
Table 2 page 21-23: Specialist AI vendors in film and TV
Table 3 page 28: Glossary
Table 4 page 29: Further reading
List of Figures
Figure 1 p4: Players Graphic
Figure 2 p5: AI value chain
Figure 3 p6: There are five categories of advanced AI capabilities
Figure 4 p7: Thematic investment matrix
Figure 5 p10: Generative AI in media presents growing opportunities
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AstraZeneca
- Bristol Myers Squibb
- Johnson & Johnson
- Lilly
- Novartis
- Pfizer
- Roche
- Sanofi
- GE Healthcare
- Illumina
- Medtronic
- Phillips
- Siemens Healthineers
